Aurora Cannabis (TSE: ACB) reported a stellar fourth quarter (ended June 2018), with revenues increasing 19% over Q3 and a whopping 223% over the corresponding quarter of last year. What makes it even more impressive is that the quarter did not include the full results of its CanniMed acquisition...
Aurora Cannabis (TSE: ACB) reported a stellar fourth quarter (ended June 2018), with revenues increasing 19% over Q3 and a whopping 223% over the corresponding quarter of last year. What makes it even more impressive is that the quarter did not include the full results of its CanniMed acquisition...
Share this Article
Recommended